FINWIRES · TerminalLIVE
FINWIRES

SNB Capital Cuts Advanced Petrochemical's PT, Keeps at Neutral

By

SNB Capital on Tuesday decreased the price target for propylene and polypropylene products company Advanced Petrochemical Co. (SASE:2330) to 27.10 Saudi riyals from 37.20 riyals and affirmed its neutral rating.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Craig Hallum Downgrades Apogee Therapeutics to Hold From Buy, $135.11 Price Target

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $122.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.63, Change: $+42.25, Percent Change: +46.75%

$APGE
Research

Citigroup Downgrades Apogee Therapeutics to Neutral From Buy, Price Target is $135

Apogee Therapeutics (APGE) has an average rating of overweight and mean price target of $119.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $132.65, Change: $+42.27, Percent Change: +46.76%

$APGE
Research

Update: Seaport Global Upgrades BWX Technologies to Buy From Neutral, Price Target is $245

(Updates with the analyst's commentary.)Seaport Global upgraded BWX Technologies (BWXT) to buy from neutral, citing the company's acquisition of Precision Components Group after a "strong" fiscal Q1.PCG 2025 revenue was about $125 million and it paid about $200 million for the firm, the brokerage said, citing BWX management.PCG is an authorized nuclear component manufacturer and certified for aerospace and defense quality-management, Seaport said.BWX Technologies has an average rating of overweight and mean price target of $240.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $212.56, Change: $+7.16, Percent Change: +3.49%

$BWXT